🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/11/2005 | 38,04 | 38,25 | 37,54 | 38,13 | +0,47% | 1,85% | 725.600 |
| 07/11/2005 | 37,95 | 38,66 | 37,40 | 37,95 | +1,88% | 3,33% | 1.066.200 |
| 04/11/2005 | 38,87 | 38,98 | 36,90 | 37,25 | -4,27% | 5,36% | 2.472.400 |
| 03/11/2005 | 38,03 | 39,37 | 37,76 | 38,91 | +3,17% | 4,23% | 2.042.600 |
| 02/11/2005 | 37,13 | 38,22 | 36,84 | 37,72 | +0,94% | 3,70% | 1.257.600 |
| 01/11/2005 | 37,06 | 37,85 | 36,45 | 37,37 | +1,18% | 3,76% | 1.462.800 |
| 31/10/2005 | 35,83 | 37,49 | 35,28 | 36,93 | +10,07% | 6,17% | 5.082.800 |
| 28/10/2005 | 34,37 | 34,62 | 33,44 | 33,55 | -0,59% | 3,45% | 3.490.400 |
| 27/10/2005 | 34,20 | 34,20 | 32,88 | 33,75 | -1,08% | 3,87% | 1.142.800 |
| 26/10/2005 | 33,42 | 34,36 | 33,34 | 34,12 | +2,32% | 3,05% | 1.692.400 |
| 25/10/2005 | 32,73 | 33,47 | 32,73 | 33,35 | +1,52% | 2,25% | 727.000 |
| 24/10/2005 | 31,59 | 32,86 | 31,59 | 32,85 | +4,27% | 4,02% | 968.000 |
| 21/10/2005 | 31,50 | 31,85 | 31,25 | 31,50 | -0,02% | 1,89% | 381.000 |
| 20/10/2005 | 31,74 | 31,95 | 31,19 | 31,51 | -1,30% | 2,38% | 730.400 |
| 19/10/2005 | 30,84 | 31,96 | 30,35 | 31,92 | +2,97% | 5,20% | 605.200 |
| 18/10/2005 | 31,51 | 31,57 | 30,71 | 31,00 | -1,56% | 2,75% | 378.600 |
| 17/10/2005 | 31,36 | 31,94 | 31,07 | 31,49 | +0,16% | 2,77% | 394.000 |
| 14/10/2005 | 31,13 | 31,99 | 31,12 | 31,44 | +1,85% | 2,79% | 915.400 |
| 13/10/2005 | 30,01 | 31,26 | 29,93 | 30,87 | +2,12% | 4,42% | 1.027.400 |
| 12/10/2005 | 31,40 | 31,59 | 30,02 | 30,23 | -3,37% | 5,02% | 1.376.800 |
| 11/10/2005 | 31,14 | 32,08 | 31,14 | 31,29 | +0,76% | 3,04% | 1.293.000 |
| 10/10/2005 | 31,33 | 32,54 | 29,82 | 31,05 | -1,10% | 8,68% | 2.570.800 |
| 07/10/2005 | 31,01 | 31,82 | 30,58 | 31,40 | -0,44% | 4,01% | 2.077.000 |
| 06/10/2005 | 33,96 | 34,33 | 31,28 | 31,54 | -7,30% | 8,98% | 2.081.400 |
| 05/10/2005 | 34,59 | 34,79 | 33,88 | 34,02 | -1,65% | 2,65% | 790.400 |
| 04/10/2005 | 35,08 | 35,75 | 34,29 | 34,59 | -1,91% | 4,18% | 795.000 |
| 03/10/2005 | 34,94 | 35,59 | 34,69 | 35,27 | +1,05% | 2,59% | 861.800 |
| 30/09/2005 | 34,18 | 35,11 | 33,95 | 34,90 | +1,90% | 3,38% | 547.000 |
| 29/09/2005 | 34,48 | 34,61 | 33,81 | 34,25 | -0,75% | 2,32% | 671.000 |
| 28/09/2005 | 34,52 | 34,88 | 34,22 | 34,51 | -0,10% | 1,91% | 535.200 |